Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

FHLC vs FSPHX overlap: 48% of top holdings shared

Bottom line

How much do FHLC and FSPHX overlap?

48% of their top holdings overlap by weight. 11 securities appear in both funds' top 25, making up 49.8% of FHLC's assets and 38.1% of FSPHX's. They share a meaningful core but differ in the rest of the portfolio.

FHLC holds far more positions (337 vs 152), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

FHLCFSPHX
Weight overlap (top 25)48%
Shared holdings11
Weight in shared holdings49.8%38.1%
Total positions337152
Expense ratio0.084%0.62%
Holdings as ofJul 31, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Holdings FHLC and FSPHX have in common

Holding% of FHLC% of FSPHXOverlap
Eli Lilly & Co13.35%8.03%8.03%
Johnson & Johnson8.93%4.91%4.91%
AbbVie Inc6.42%2.03%2.03%
UnitedHealth Group Inc5.44%3.49%3.49%
Merck & Co Inc4.66%1.60%1.60%
Thermo Fisher Scientific Inc3.09%4.33%3.09%
Gilead Sciences Inc2.34%2.21%2.21%
CVS Health Corp1.92%1.29%1.29%
Danaher Corp1.80%6.89%1.80%
Boston Scientific Corp1.00%2.17%1.00%
Cencora Inc0.83%1.14%0.83%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in FHLC

  1. Amgen Inc — 3.00%
  2. Abbott Laboratories — 2.66%
  3. Pfizer Inc — 2.06%
  4. Bristol-Myers Squibb Co — 1.93%
  5. Intuitive Surgical Inc — 1.82%
  6. Vertex Pharmaceuticals Inc — 1.76%
  7. Stryker Corp — 1.62%
  8. Medtronic PLC — 1.59%
  9. McKesson Corp — 1.52%
  10. Elevance Health Inc — 1.19%
  11. Regeneron Pharmaceuticals Inc — 1.15%
  12. Cigna Group/The — 1.06%
  13. HCA Healthcare Inc — 0.91%
  14. Cardinal Health Inc — 0.78%

Only in FSPHX

  1. Alnylam Pharmaceuticals Inc — 2.40%
  2. Ascendis Pharma A/s — 2.17%
  3. Fidelity Revere Street Trust — 2.17%
  4. Ucb Sa — 2.03%
  5. Bio Techne Corp — 1.70%
  6. Argenx Se — 1.56%
  7. Nuvalent Inc — 1.28%
  8. Natera Inc — 1.27%
  9. Brightspring Health Services Inc — 1.23%
  10. Viatris Inc — 1.20%
  11. Moderna Inc — 1.18%
  12. West Pharmaceutical Svcs Inc — 1.12%
  13. Agilent Technologies Inc — 1.10%
  14. Edwards Lifesciences Corp — 1.09%

Asset mix

Asset typeFHLCFSPHX
Stocks99.7%97.7%
Cash & short-term funds0.2%2.4%
Preferred stock—2.0%
Bonds—0.1%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Country mix

CountryFHLCFSPHX
US96.5%87.0%
NL0.1%2.4%
IE2.2%1.0%
DK—2.2%
GB0.5%2.1%
BE—2.0%
CH0.1%1.4%
KY—1.4%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Check another pair

FAQ

How much do FHLC and FSPHX overlap?
About 48% by weight. 11 securities appear in both funds' top 25 holdings; they make up 49.8% of FHLC's assets and 38.1% of FSPHX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do FHLC and FSPHX have in common?
The largest shared holdings are Eli Lilly & Co, Johnson & Johnson, UnitedHealth Group Inc, Thermo Fisher Scientific Inc, Gilead Sciences Inc.
Should I own both FHLC and FSPHX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, FHLC or FSPHX?
FHLC is broader, with 337 positions versus 152 for FSPHX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.